pillbase.ru

Vraylar

Active substance: cariprazine

CAPSULE, GELATIN COATED · CARIPRAZINE 1.5 mg/1

United StatesActive

Marketing holder: Allergan, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 3
  • Реагила®
    капсулы, 1.5 мг (original in Russian, GRLS)
    ЛП-№(001510)-(РГ-RU)
    ОАО "Гедеон Рихтер"
  • Реагила®
    таблетки, диспергируемые в полости рта, 1.5 мг (original in Russian, GRLS)
    ЛП-№(014524)-(РГ-RU)
    ОАО "Гедеон Рихтер"
  • Реагила®
    капсулы, 1.5 мг (original in Russian, GRLS)
    ЛП-005405
    ОАО "Гедеон Рихтер"
EU 1
  • Reagila
    cariprazine hydrochloride
    EMEA/H/C/002770
    Gedeon Richter
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-3fbb-7d74-b697-5506f1700e1a,01a120c3-e287-7872-b683-946cfaca933e,01a120c5-ce7b-7ace-85f4-156fe212864c;count=3 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12090-148a-75a4-8126-4a749f5587a8,01a12093-f5ec-7d8b-a3cd-a20bcf8ff3fc,01a12093-f5f2-76ea-a407-daf238d8ca5e,01a12096-8c97-7795-bbdb-28bcf77dfcff,01a12098-ed40-7e95-9e80-68f073e508f6;count=7 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
61874-115
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 61874-115 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 61874-115 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 61874-115 · Verified 2026-10-09 · open in source